Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Watkins

Showing results (751-760 of 845) with videos related to

Pageof 85
Sort By:
ACS Chemical Neuroscience|July 9, 2019
Methamphetamine Activates Toll-Like Receptor 4 to Induce Central Immune Signaling within the Ventral Tegmental Area and Contributes to Extracellular Dopamine Increase in the Nucleus Accumbens ShellXiaohui Wang, Alexis L Northcutt, Thomas A Cochran, et al.
The Journal of Pain|May 4, 2010
Pain intensity and duration can be enhanced by prior challenge: initial evidence suggestive of a role of microglial primingLeah E Hains, Lisa C Loram, Julie L Weiseler, et al.
Neuroscience|April 13, 2010
Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activityM R Hutchinson, L C Loram, Y Zhang, et al.
The European Journal of Neuroscience|May 5, 2005
Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10Erin D Milligan, Stephen J Langer, Evan M Sloane, et al.
Applied Microbiology and Biotechnology|April 28, 2016
Manufacturing demonstration of microbially mediated zinc sulfide nanoparticles in pilot-plant scale reactorsJi-Won Moon, Tommy J Phelps, Curtis L Fitzgerald, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 6, 2009
Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine 2A receptor agonists: a novel therapy for neuropathic painLisa C Loram, Jacqueline A Harrison, Evan M Sloane, et al.
Brain, Behavior, and Immunity|August 19, 2008
Minocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced reward, and enhances systemic morphine-induced analgesiaMark R Hutchinson, Alexis L Northcutt, Lindsey W Chao, et al.
Pain|June 30, 2016
Prior voluntary wheel running attenuates neuropathic painPeter M Grace, Timothy J Fabisiak, Suzanne M Green-Fulgham, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 5, 2019
Stereochemistry and innate immune recognition: (+)-norbinaltorphimine targets myeloid differentiation protein 2 and inhibits toll-like receptor 4 signalingXiaozheng Zhang, Yinghua Peng, Peter M Grace, et al.
Journal of Affective Disorders Reports|May 21, 2024
State rumination predicts inhibitory control failures and dysregulation of default, salience, and cognitive control networks in youth at risk of depressive relapse: Findings from the RuMeChange trialHenrietta Roberts, Mindy Westlund Schreiner, Stephanie Pocius, et al.
Pageof 85

Showing results (751-760 of 845) with videos related to

Sort By:
Pageof 85
ACS Chemical Neuroscience|July 9, 2019
Methamphetamine Activates Toll-Like Receptor 4 to Induce Central Immune Signaling within the Ventral Tegmental Area and Contributes to Extracellular Dopamine Increase in the Nucleus Accumbens ShellXiaohui Wang, Alexis L Northcutt, Thomas A Cochran, et al.
The Journal of Pain|May 4, 2010
Pain intensity and duration can be enhanced by prior challenge: initial evidence suggestive of a role of microglial primingLeah E Hains, Lisa C Loram, Julie L Weiseler, et al.
Neuroscience|April 13, 2010
Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activityM R Hutchinson, L C Loram, Y Zhang, et al.
The European Journal of Neuroscience|May 5, 2005
Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10Erin D Milligan, Stephen J Langer, Evan M Sloane, et al.
Applied Microbiology and Biotechnology|April 28, 2016
Manufacturing demonstration of microbially mediated zinc sulfide nanoparticles in pilot-plant scale reactorsJi-Won Moon, Tommy J Phelps, Curtis L Fitzgerald, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 6, 2009
Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine 2A receptor agonists: a novel therapy for neuropathic painLisa C Loram, Jacqueline A Harrison, Evan M Sloane, et al.
Brain, Behavior, and Immunity|August 19, 2008
Minocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced reward, and enhances systemic morphine-induced analgesiaMark R Hutchinson, Alexis L Northcutt, Lindsey W Chao, et al.
Pain|June 30, 2016
Prior voluntary wheel running attenuates neuropathic painPeter M Grace, Timothy J Fabisiak, Suzanne M Green-Fulgham, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 5, 2019
Stereochemistry and innate immune recognition: (+)-norbinaltorphimine targets myeloid differentiation protein 2 and inhibits toll-like receptor 4 signalingXiaozheng Zhang, Yinghua Peng, Peter M Grace, et al.
Journal of Affective Disorders Reports|May 21, 2024
State rumination predicts inhibitory control failures and dysregulation of default, salience, and cognitive control networks in youth at risk of depressive relapse: Findings from the RuMeChange trialHenrietta Roberts, Mindy Westlund Schreiner, Stephanie Pocius, et al.
Pageof 85